Dr. Gernot Berger

Senior Investment Manager

Dr. Gernot Berger is a physicist with a strong affinity for the strategic development of companies. He was co-owner of a start-up company and contributed significantly to its success as sales, marketing and product manager. With his keen sense of market requirements and business development, he helped to establish the invention as a worldwide industry standard in optics manufacturing after the exit. Parallel to his work, he earned an Executive MBA from the Mannheim Business School in 2018, which focuses on entrepreneurship and strategic leadership. Before joining HTGF in 2019, Gernot used his strategic knowledge profitably for a medium-sized company selling high-tech B2B products in the highly competitive 3C industry with complex stakeholder structures.

Portfolio

Posts & mentions

Press
16. September 2024

Deep tech startup Samp raises €6M to speed up the deployment of its digital twin solution for sensitive industrial sites

Paris, 16 September 2024 — Samp, the first AI-generated digital twin solution that establishes a constant understanding of sensitive industrial sites in a matter of days, announced the closing of a 6M euro fundraising round. This strategic capital injection from tech investors Promus Ventures and Kvanted will allow the company to scale up and deploy its innovative “Shared Reality” solution internationally. A startup at the heart of the 4.0 industrial revolution Founded in 201
 
Press
23. August 2023

beeOLED raises EUR 13.3m in Series A funding from world-class deep tech investors to solve the last big challenge of the OLED industry

The German deep tech startup will use the investment to further develop its innovative, high-efficiency, deep-blue emitter technology towards go-to-market-readiness. Dresden, 23 August 2023 – beeOLED, a Dresden-based deep-tech startup, today announced it has raised EUR 13.3m for a Series A funding co-led by eCAPITAL and Innovation Industries. The round was joined by KBC Focus Fund as well as existing investors M Ventures (the corporate venture capital arm of Merck KGaA, Darmstadt, G